RHÖN-KLINIKUM マネジメント

マネジメント基準チェック /44

現在、CEO に関する十分な情報がありません。

主要情報

Tobias Kaltenbach

最高経営責任者

€507.0k

報酬総額

CEO給与比率	98.6%
CEO在任期間	2yrs
CEOの所有権	n/a
経営陣の平均在職期間	4.2yrs
取締役会の平均在任期間	4.3yrs

経営陣の近況

Recent updates

CEO報酬分析

RHÖN-KLINIKUM の収益と比較して、Tobias Kaltenbach の報酬はどのように変化したか？
日付	総報酬	給与	会社業績
Sep 30 2024	n/a	n/a	€45m
Jun 30 2024	n/a	n/a	€47m
Mar 31 2024	n/a	n/a	€43m
Dec 31 2023	€507k	€500k	€39m
Sep 30 2023	n/a	n/a	€32m
Jun 30 2023	n/a	n/a	€26m
Mar 31 2023	n/a	n/a	€30m
Dec 31 2022	€547k	€83k	€25m

報酬と市場: Tobiasの総報酬 ($USD 534.75K ) は、 Swiss市場 ($USD 1.36M ) の同様の規模の企業の平均を下回っています。

報酬と収益: Tobiasの報酬は、過去 1 年間の会社の業績と一致しています。

CEO（最高経営責任者

Tobias Kaltenbach (64 yo)

2yrs

在職期間

€507,000

報酬

Dr. Tobias Kaltenbach is Chief Executive Officer & Chairman of the Management Board at RHÖN-KLINIKUM Aktiengesellschaft from November 2022. Mr. Kaltenbach served as Chairman of Corporate Management at Askl...

リーダーシップ・チーム

名称	ポジション	在職期間	報酬	所有権
Tobias Kaltenbach	CEO & Chairman of Management Board	2yrs	€507.00k	データなし
Stefan Stranz	CFO & Member of Management Board	4.2yrs	€543.00k	データなし
Gunther Weiß	COO & Member of Management Board	6.5yrs	€625.00k	データなし
Julian Schmitt	Head of Investor Relations & Treasury	no data	データなし	データなし
Eugen Münch	Chief Representative	4.3yrs	€219.00k	データなし

4.2yrs

平均在職期間

56yo

平均年齢

経験豊富な経営陣: RHKの経営陣は経験豊富であると考えられます ( 4.2年の平均在職年数)。

取締役

名称	ポジション	在職期間	報酬	所有権
Irmtraut Gurkan	Member of Supervisory Board	4.3yrs	€43.00k	データなし
Peter Berghofer	Member of Supervisory Board	14.4yrs	€45.00k	データなし
Oliver Salomon	Member of Supervisory Board	6.7yrs	€34.00k	データなし
Christine Reißner	Member of Supervisory Board	9.4yrs	€33.00k	データなし
Hafid Rifi	Second Deputy Chairman of the Supervisory Board	4.3yrs	€69.00k	データなし
Jan Liersch	Chairman of Supervisory Board	4.4yrs	€102.00k	データなし
Peter Ducke	Member of Supervisory Board	4.3yrs	€39.00k	データなし
Regina Dickey	Member of Supervisory Board	4.3yrs	€45.00k	データなし
Thomas Pillukat	Member of Supervisory Board	4.3yrs	€37.00k	データなし
Julia Dannath-Schuh	Member of Supervisory Board	4.4yrs	€31.00k	データなし
Martin Mandewirth	Member of Supervisory Board	4.3yrs	€35.00k	データなし
Stefan Rohrhoff	First Deputy Chairman of the Supervisory Board	less than a year	データなし	データなし

4.3yrs

平均在職期間

経験豊富なボード: RHKの取締役会は経験豊富であると考えられます ( 4.3年の平均在任期間)。

RHÖN-KLINIKUM マネジメント

マネジメント 基準チェック /44

主要情報

経営陣の近況

RHÖN-KLINIKUM Aktiengesellschaft, Annual General Meeting, Jun 09, 2021

RHÖN-KLINIKUM Aktiengesellschaft appoints Christian Höftberger as new CEO

Recent updates

RHÖN-KLINIKUM Aktiengesellschaft to Report Nine Months, 2025 Results on Nov 06, 2025

Second quarter 2024 earnings released: EPS: €0.14 (vs €0.09 in 2Q 2023)

First quarter 2024 earnings released: EPS: €0.16 (vs €0.09 in 1Q 2023)

Full year 2023 earnings released: EPS: €0.58 (vs €0.38 in FY 2022)

RHÖN-KLINIKUM Aktiengesellschaft to Report Q2, 2024 Results on Aug 08, 2024

Third quarter 2023 earnings released: EPS: €0.17 (vs €0.069 in 3Q 2022)

Second quarter 2023 earnings released: EPS: €0.09 (vs €0.16 in 2Q 2022)

Upcoming dividend of €0.15 per share at 1.2% yield

Full year 2022 earnings released: EPS: €0.38 (vs €0.42 in FY 2021)

RHÖN-KLINIKUM Aktiengesellschaft to Report Fiscal Year 2022 Results on Mar 30, 2023

Second quarter 2022 earnings released: EPS: €0.16 (vs €0.10 in 2Q 2021)

First quarter 2022 earnings released: EPS: €0.01 (vs €0.017 in 1Q 2021)

Third quarter 2021 earnings released: EPS €0.10 (vs €0.09 in 3Q 2020)

Second quarter 2021 earnings released: EPS €0.10 (vs €0.003 in 2Q 2020)

First quarter 2021 earnings released: EPS €0.02 (vs €0.066 loss in 1Q 2020)

RHON-KLINIKUM AG Provides Revenue Guidance for the Year 2021

Full year 2020 earnings released: EPS €0.02 (vs €0.65 in FY 2019)

RHÖN-KLINIKUM Aktiengesellschaft to Report Q2, 2021 Results on Aug 05, 2021

RHÖN-KLINIKUM Aktiengesellschaft to Report Fiscal Year 2020 Results on Feb 25, 2021

New 90-day low: CHF26.00

New 90-day low: CHF26.00

New 90-day low: CHF26.00

New 90-day low: CHF26.00

RHÖN-KLINIKUM Aktiengesellschaft, Annual General Meeting, Jun 09, 2021

RHÖN-KLINIKUM Aktiengesellschaft to Report Q4, 2020 Final Results on Mar 25, 2021

Third quarter 2020 earnings released: EPS €0.09

RHÖN-KLINIKUM Aktiengesellschaft appoints Christian Höftberger as new CEO

New 90-day low: CHF26.00

Medgate Holding AG acquired remaining 51% stake in Medgate Deutschland GmbH from RHÖN-KLINIKUM Aktiengesellschaft (XTRA:RHK).

RHÃ–N-KLINIKUM Aktiengesellschaft to Report Nine Months, 2020 Results on Nov 06, 2020

Asklepios Kliniken GmbH & Co. KGaA completed the acquisition of additional 42.5% stake in RHÖN-KLINIKUM Aktiengesellschaft (XTRA:RHK) from HCM SE, B. Braun Melsungen AG, Landeskrankenhilfe V.V.A.G, Asset Management Arm and others for approximately €510 million.

Asklepios Kliniken GmbH concluded the acquisition of additional 12.4% stake in RHÖN-KLINIKUM Aktiengesellschaft (XTRA:RHK) from Eugen Münch and Ingeborg Münch.

CEO報酬分析

CEO（最高経営責任者

在職期間

報酬

リーダーシップ・チーム

平均在職期間

平均年齢

取締役

平均在職期間

マネジメント基準チェック /44